NEUROPATHIX
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing a patented product platform of novel molecules from our proprietary socially responsible pain management therapeutics to treat patients with a variety of unmet medical needs
NEUROPATHIX
Industry:
Biotechnology Pharmaceutical
Address:
Doylestown, Pennsylvania, United States
Country:
United States
Website Url:
http://www.neuropathix.com
Status:
Active
Contact:
(215) 695-6559
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Wordpress Plugins
Similar Organizations
Dyax
Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Telesta Therapeutics
Telesta Therapeutics is a biopharmaceutical company focused on the licensing, acquisition, and development of transformational therapeutics.
Stock Details
Official Site Inspections
http://www.neuropathix.com Semrush global rank: 5.64 M Semrush visits lastest month: 1.5 K
- Host name: 116.22.197.104.bc.googleusercontent.com
- IP address: 104.197.22.116
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Neuropathix"
Homepage - Neuropathix, Inc. - Breakthrough Therapeutics …
Neuropathix, Inc. is a biopharmaceutical company focused on the research and development of a pipeline of next generation breakthrough therapeutics targeting inflammation to treat patients …See details»
About - Neuropathix, Inc. - Breakthrough Therapeutics Targeting ...
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from our proprietary socially …See details»
The Company - Neuropathix, Inc. – Socially Responsible Pain …
Neuropathix, Inc. (OTCQB: NPTX) is a biopharmaceutical company focused on the research and development of a pipeline of next generation, socially responsible pain management and …See details»
Neuropathix - Wikipedia
Neuropathix, Inc. is a biopharmaceutical company based in Doylestown, Pennsylvania focused on the research and development of pain management and neuroprotective therapeutics. In 2016, through the company's subsidiary Kannalife, Neuropathix discovered KLS-13019 along with other therapeutic agents that prevent neuropathic pain, See details»
Neuropathix - Crunchbase Company Profile & Funding
Neuropathix is a biopharmaceutical company focused on the research and development of breakthrough anti-inflammatory therapeutics. View contacts for Neuropathix to access new …See details»
Neuropathix, Inc. - LinkedIn
Neuropathix is a biopharmaceutical company focused on the research and development of a pipeline of next generation socially responsible pain management therapeutics to treat patients with...See details»
Homepage - Kannalife Sciences, Inc. – A Neuropathix …
KannaLife Sciences, Inc. (a subsidiary of Neuropathix, Inc.) is a biopharmaceutical company focused on the research and development of a pipeline of next generation breakthrough therapeutics targeting inflammation …See details»
Neuropathix, Inc. Company Profile | Doylestown, PA | Competitors ...
Find company research, competitor information, contact details & financial data for Neuropathix, Inc. of Doylestown, PA. Get the latest business insights from Dun & Bradstreet.See details»
Neuropathix - Contacts, Employees, Board Members, Advisors
Neuropathix is a biopharmaceutical company focused on the research and development of breakthrough anti-inflammatory therapeutics.See details»
Robert Malasek - Director at Neuropathix - The Org
Director at Neuropathix Contact Mr. Malasek’s experience includes serving as the Assistant Controller for Starwood Hotel & Resorts Worldwide, Inc. and as Chief Financial Officer for …See details»
Leadership - Neuropathix, Inc. - Breakthrough …
The Neuropathix leadership team has more than 40 years of business, marketing and drug development experience with Fortune 500, Pharma and leading Biotechnology firms.See details»
Timothy Scott - Director at Neuropathix - The Org
Scott holds decades of experience at senior management and board levels in public and private companies which is a great benefit to the company and its board of directors. Dr. Scott brings …See details»
Neuropathix, Inc. Reveals Visual Identity to Coincide With
Nov 12, 2020 · Neuropathix, Inc., formerly Kannalife, Inc. ("Neuropathix"), is a socially responsible pain management life sciences company focused on the development of proprietary and …See details»
Neuropathix, Inc. CEO Issues New Letter to Shareholders; Updates …
Apr 6, 2022 · Neuropathix has designated proprietary, cannabinoid-derivative compound KLS-13019 as lead drug candidate for the treatment of neuropathic pain, a viable alternative to …See details»
Michael Ropacki - Scientific Advisor at Neuropathix - The Org
Dr. Michael Ropacki is the Chief Medical Officer (CMO) CNS Clinical Development and US Site Head for Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging …See details»
Neuropathix, Inc. Appoints Michael Ropacki, PhD to the …
Aug 12, 2021 · Ropacki will be advising Neuropathix's management team regarding the development of their lead drug candidate KLS-13019 into the clinic, as well as positioning …See details»
Neuropathix, Inc. Chooses Purisys for Process Optimization and …
Nov 17, 2021 · Purisys is based in Athens, Georgia, and specializes in the synthetic manufacture of Active Pharmaceutical Ingredients (APIs), CDMO services, and reference …See details»
Neuropathix, Inc. Acquires Neuroprotective and - GlobeNewswire
Dec 21, 2020 · Neuropathix is a biopharmaceutical company focused on the research and development of a pipeline of next generation socially responsible pain management and …See details»
Neuropathix, Inc. total equity 2021 - Statista
Nov 1, 2024 · The total equity of Neuropathix, Inc. with headquarters in the United States amounted to -3.99 million U.S. dollars in 2021. The reported fiscal year ends on December 31. …See details»
Neuropathix, Inc. Announces Publication of Its Global PCT
Jan 19, 2021 · --Neuropathix, Inc., a socially responsible pain management life sciences company, announced the publication of its global WIPO/PCT Patent WO 2020/ 264324–" Use …See details»